PMC:7161517 / 1196-1330 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":70,"end":73},"obj":"Body_part"},{"id":"T5","span":{"begin":126,"end":129},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":70,"end":73},"obj":"Chemical"},{"id":"T16","span":{"begin":126,"end":129},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}

{"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":27,"end":74},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":6,"end":13},"obj":"UBERON:0000948"},{"id":"T34","span":{"begin":27,"end":37},"obj":"SP_7"},{"id":"T35","span":{"begin":58,"end":62},"obj":"G_3;PG_10;PR:000003622"},{"id":"T36","span":{"begin":82,"end":86},"obj":"G_3;PG_10;PR:000003622"},{"id":"T37","span":{"begin":87,"end":91},"obj":"PR:000036013"},{"id":"T97887","span":{"begin":6,"end":13},"obj":"UBERON:0000948"},{"id":"T56833","span":{"begin":27,"end":37},"obj":"SP_7"},{"id":"T99319","span":{"begin":58,"end":62},"obj":"G_3;PG_10;PR:000003622"},{"id":"T59141","span":{"begin":82,"end":86},"obj":"G_3;PG_10;PR:000003622"},{"id":"T38767","span":{"begin":87,"end":91},"obj":"PR:000036013"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}

{"project":"LitCovid-PubTator","denotations":[{"id":"44","span":{"begin":58,"end":62},"obj":"Gene"},{"id":"45","span":{"begin":27,"end":37},"obj":"Species"},{"id":"47","span":{"begin":6,"end":25},"obj":"Disease"},{"id":"50","span":{"begin":82,"end":86},"obj":"Gene"},{"id":"51","span":{"begin":87,"end":93},"obj":"Gene"}],"attributes":[{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Gene:59272"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:2697049"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D006331"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Gene:59272"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Gene:284"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, whi"}